Abstract
Summary
The association between hyponatremia and osteoporosis was evaluated in humans. A significant association was found between low sodium levels, lower bone mineralization in the hip, and with several common conditions. Hyponatremia could be used as a marker of osteoporosis and systemic disease.
Introduction
The objective of this study was to evaluate the association between hyponatremia and osteoporosis in humans through a cross-sectional study.
Methods
Patient information was gathered from regional and national Danish patient databases, both in- and outpatient settings, from 2004 to 2011. Patients with dual-energy x-ray absorptiometry (DXA) scans performed within this time were included if accompanied [Na+] was measured within 14 days prior or past the scan date. A total of 1575 patients were included.
Results
A total of 104 patients were hyponatremic (6.6 %). Total hip and lumbar spine bone mineral content (BMC) and densities (BMD) and T-scores were all significantly lower with hyponatremia. The odds ratio (OR) of osteoporosis significantly increased among hyponatremic patients at both total hip (unadjusted OR = 2.17, 95 % CI = [1.40–3.34], p < .05) and lumbar spine (unadjusted OR = 1.83, 95 % CI = [1.20–2.80], p < .05) regions. Dose-response found between increasing [Na+] and increasing total hip BMC (slope .174, adjusted p < .05), BMD (slope .004, adjusted p < .05), and T-score (slope .034, adjusted p < .05). Systemic disease was more prevalent in hyponatremia.
Conclusion
The presence of hyponatremia increases the risk of concurrent osteoporosis at both the total hip and lumbar spine in humans. Hyponatremia could be used a screening tool and marker of secondary osteoporosis.
Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Adrogué HJ, Madias NE (2000) Hyponatremia. N Engl J Med 342(21):1581–1589
Holm EA, Brorson SW, Kruse JS, Faber JO, Jespersen B (2004) Hyponatremia in acutely admitted medical patients—occurrence and causes. Ugeskr Laeger 166(45):4033–4037
Kleinfeld M, Casimir M, Borra S (1979) Hyponatremia as observed in a chronic disease facility. J Am Geriatr Soc 27(4):156–161
Miller M, Hecker MS, Friedlander DA, Carter JM (1996) Apparent idiopathic hyponatremia in an ambulatory geriatric population. J Am Geriatr Soc 44(4):404–408
Miller M, Morley JE, Rubenstein LZ (1995) Hyponatremia in a nursing home population. J Am Geriatr Soc 43(12):1410–1413
Verbalis JG, Barsony J, Sugimura Y, Tian Y, Adams DJ, Carter EA, Resnick HE (2010) Hyponatremia-induced osteoporosis. J Bone Miner Res 25(3):554–563
Sejling AS, Pedersen-bjergaard U, Eiken P (2012) Syndrome of inappropriate ADH secretion and severe osteoporosis. J Clin Endocrinol Metab 97(12):4306–4310
Chow KM, Szeto CC, Kwan BC, Ma TK, Leung CB, Li PK (2012) Fracture risk after thiazide-associated hyponatraemia. Intern Med J 42(7):760–764
Ayus JC, Arieff AI (1999) Chronic hyponatremic encephalopathy in postmenopausal women: association of therapies with morbidity and mortality. JAMA 281(24):2299–2304
Hoorn EJ, Rivadeneira F, van Meurs JB et al (2011) Mild hyponatremia as a risk factor for fractures: the Rotterdam study. J Bone Miner Res 26(8):1822–1828
Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO study group. Osteoporos Int 4(6):368–381
Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G (2006) Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 119(1):71.e1–8
Sandhu HS, Gilles E, Devita MV, Panagopoulos G, Michelis MF (2009) Hyponatremia associated with large-bone fracture in elderly patients. Int Urol Nephrol 41(3):733–737
Abrahamsen B, Gram J, Hansen TB, Beck-Nielsen H (1995) Cross calibration of QDR-2000 and QDR-1000 dual-energy X-ray densitometers for bone mineral and soft-tissue measurements. Bone 16(3):385–390
Seeliger E, Ladwig M, Reinhardt HW (2006) Are large amounts of sodium stored in an osmotically inactive form during sodium retention? Balance studies in freely moving dogs. Am J Physiol Regul Integr Comp Physiol 290(5):R1429–R1435
Sejling AS, Thorsteinsson AL, Pedersen-Bjergaard U, Eiken P (2014) Recovery from SIADH associated osteoporosis - a case report. J Clin Endocrinol Metab: jc20141572
Schmidt C, Höcherl K, Schweda F, Kurtz A, Bucher M (2007) Regulation of renal sodium transporters during severe inflammation. J Am Soc Nephrol 18(4):1072–1083
Swart RM, Hoorn EJ, Betjes MG, Zietse R (2011) Hyponatremia and inflammation: the emerging role of interleukin-6 in osmoregulation. Nephron Physiol 118(2):45–51
Eisenhut M (2006) Changes in renal sodium transport during a systemic inflammatory response. Pediatr Nephrol 21(10):1487–1488
Arakelyan KP, Sahakyan YA, Hayrapetyan LR, Khudaverdyan DN, Ingelman-Sundberg M, Mkrtchian S, Ter-Markosyan AS (2007) Calcium-regulating peptide hormones and blood electrolytic balance in chronic heart failure. Regul Pept 142(3):95–100
Rejnmark L, Vestergaard P, Mosekilde L (2005) Reduced fracture risk in users of thiazide diuretics. Calcif Tissue Int 76(3):167–175
Jespersen B, Randløv A, Abrahamsen J, Fogh-Andersen N, Kanstrup IL (1997) Effects of PTH(1–34) on blood pressure, renal function, and hormones in essential hypertension: the altered pattern of reactivity may counteract raised blood pressure. Am J Hypertens 10(12 Pt 1):1356–1367
Resnick LM, Laragh JH (1985) Calcium metabolism and parathyroid function in primary aldosteronism. Am J Med 78(3):385–390
Aggarwal HK, Jain D, Yadav S, Kaverappa V (2013) Bone mineral density in patients with predialysis chronic kidney disease. Ren Fail 35(8):1105–1111
Amerling R, Harbord NB, Pullman J, Feinfeld DA (2010) Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series. Blood Purif 29(3):293–299
Heaf J, Tvedegaard E, Kanstrup IL, Fogh-Andersen N (2000) Bone loss after renal transplantation: role of hyperparathyroidism, acidosis, cyclosporine and systemic disease. Clin Transplant 14(5):457–463
Abdelhadi M, Eriksson SA, Ljusk Eriksson S, Ericzon BG, Nordenström J (1995) Bone mineral status in end-stage liver disease and the effect of liver transplantation. Scand J Gastroenterol 30(12):1210–1215
Díez-Ruiz A, García-Saura PL, García-Ruiz P, González-Calvin JL, Gallego-Rojo F, Fuchs D (2010) Bone mineral density, bone turnover markers and cytokines in alcohol-induced cirrhosis. Alcohol 45(5):427–430
Monegal A, Navasa M, Peris P et al (2013) Bone disease in patients awaiting liver transplantation. Has the situation improved in the last two decades? Calcif Tissue Int 93(6):571–576
Wibaux C, Legroux-Gerot I, Dharancy S et al (2011) Assessing bone status in patients awaiting liver transplantation. Joint Bone Spine 78(4):387–391
Conflicts of interest
CK declares no competing interests. PE is an advisory board member with Amgen, MSD and Eli Lilly and at the speakers bureau with Amgen and Eli Lilly. PV has received unrestricted grants from MSD and Servier and travel grants from Amgen, Eli Lilly, Novartis, Sanofi-Aventis, and Servier.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kruse, C., Eiken, P. & Vestergaard, P. Hyponatremia and osteoporosis: insights from the Danish National Patient Registry. Osteoporos Int 26, 1005–1016 (2015). https://doi.org/10.1007/s00198-014-2973-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-014-2973-1